Results
eNauka >
Results >
APOLLO: Phase 3 randomized study of subcutaneous Daratumumab plus Pomalidomide and Dexamethasone (D-Pd) versus Pomalidomide and Dexamethasone (Pd) alone in patients with Relapsed/Refractory Multiple Myeloma (RRMM)
| Title: | APOLLO: Phase 3 randomized study of subcutaneous Daratumumab plus Pomalidomide and Dexamethasone (D-Pd) versus Pomalidomide and Dexamethasone (Pd) alone in patients with Relapsed/Refractory Multiple Myeloma (RRMM) | Authors: | Einsele, Hermann; ...; Bila, Jelena S.   ; ...; (broj koautora 23) |
Issue Date: | 2021 | Publication: | Oncology research and treatment (Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (Hybrid-Kongress), 01.-04. Oktober 2021: Abstracts) | ISSN: | 2296-5270 Oncology Research and Treatment Search Idenfier |
Publisher: | Basel : S. Karger | Type: | Conference Paper | Collation: | vol. 44 br. Suppl 2 str. 178-178 | WoS-ID: | 000760622600326 | URI: | https://enauka.gov.rs/handle/123456789/823634 | URL: | https://karger.com/ort/article-pdf/44/Suppl.%202/1/4141036/000518417.pdf | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Google ScholarTM
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.